Table 2 Profile of the thyroid function and thyroid autoantibodies of premenopausal female patients with Graves' disease compared to both healthy controls and patients with Hashimoto's thyroiditis on stable levothyroxine replacement.

Baseline

3

18 ± 3

36 ± 3

19

32

18

1.5

< 0.01^##

0.2**

1.1**

0.6**

1.2^NS

(1.3-1.7)

(< 0,01-0.02)

(0.1-0.5)

(0.8-1.9)

(0.4-1.0)

(0.4-3.7)

91

246^##

93**

98**

103**

105 ^NS

(84-98)

(231-263)

(76-115)

(91-105)

(92-115)

(92-120)

14

51^##

15**

14**

15**

16 ^NS

(14-15)

(45-56)

(13-18)

(13-15)

(14-16)

(14-18)

1.5

5.4^##

1.8**

1.5**

1.5**

1.6 ^NS

(1.3-1.7)

(4.6-6.3)

(1.5-2.2)

(1.4-1.7)

(1.3-1.7)

(1.5-1.8)

5.2

24^##

5.8**

4.6**

4.2**

5.7 ^NS

(4.7-5.8)

(19-30)

(4.6-7.2)

(4.3-4.9)

(3.8-4.8)

(4.9-6.7)

< 1.0

7.3^##

4.1**

2.0**

1.2**

< 1.0

(4.9-10.8)

(2.6-6.2)

(1.3-2.9)

(0.8-1.8)

< 60

292^##

206^NS

174*

249^NS

1452^##

(166-513)

(121-349)

(107-282)

(143-435)

(785-2686)